Company intelligence / Profile preview

Reebio

Ningbo, Zhejiang, Chinareebio.com ↗

Ownership: Private
Development stage: Commercial

Overview

Reebio develops, manufactures, and sells in vitro diagnostic reagents. It operates as a national high-tech enterprise with R&D and production capabilities focused on the IVD sector. No clinical trial results are relevant as it does not develop therapeutics.

Therapeutic areas: Other
Modalities: In vitro diagnostic reagents
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Reebio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reebio.

Explore the full profile